N-Hydroxysulfosuccinimide sodium

CAS No. 106627-54-7

N-Hydroxysulfosuccinimide sodium( —— )

Catalog No. M23271 CAS No. 106627-54-7

N-Hydroxysulfosuccinimide sodium is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 42 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Hydroxysulfosuccinimide sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Hydroxysulfosuccinimide sodium is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • Description
    N-Hydroxysulfosuccinimide sodium is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Antibody Drug Conjugates (ADC)
  • Target
    ADCs Linker/Click Chemistry
  • Recptor
    Non-cleavable
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    106627-54-7
  • Formula Weight
    217.13
  • Molecular Formula
    C4H4NNaO6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1C(C(=O)N(C1=O)O)S(=O)(=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
molnova catalog
related products
  • FMOC-3VVD-OH

    FMOC-3VVD-OH is an active chemical.

  • Amino-PEG8-Boc

    Amino-PEG8-Boc is a cleavable 8 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-PEG8-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • BS3 Crosslinker

    BS3 Crosslinker is a non-cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). It connects antibodies with drugs, thereby enhancing the overall efficiency and effectiveness of the resulting ADC.